Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate 08:29:57 2026-09-02 am EDT			5-day change	1st Jan Change
59.95 ^EUR	-0.08%		-1.48%	-5.67%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.56B		BBB
ELI LILLY AND COMPANY	1,034B		A
JOHNSON & JOHNSON	654B	-	BBB	-	-
ABBVIE INC.	459B		AA		-
ROCHE HOLDING AG	343B		AA
NOVARTIS AG	307B		AAA
ASTRAZENECA PLC	251B		A
AMGEN INC.	237B		A
NOVO NORDISK A/S	202B		A
GILEAD SCIENCES, INC.	186B		AA
PFIZER INC.	163B		A
VERTEX PHARMACEUTICALS INCORPORATED	139B		AA
BRISTOL-MYERS SQUIBB COMPANY	137B		A
SANOFI	107B		AA
GSK PLC	101B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	71.27B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	58.3B		AA
BAYER AG	55.67B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	45.28B		AA
HALEON PLC	44.08B		AA
Average	229.81B		AA
Weighted average by Cap.			AA